Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis

International Journal of Medical Microbiology

Volumn 298, Issue 1-2, 2008, Pages 79-86

  Lotter, Hannelore ^a   Rüssmann, Holger ^b   Heesemann, Jürgen ^b   Tannich, Egbert ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amoebiasis; Entamoeba histolytica; Type III secretion system; Vaccine; Yersinia enterocolitica

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 4; LECTIN; LIVE VACCINE; PROTEIN SUBUNIT; YERSINIA OUTER PROTEIN E;

AMEBIASIS; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; BACTERIAL STRAIN; CELLULAR IMMUNITY; DRUG EFFICACY; ENTAMOEBA HISTOLYTICA; GENDER; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; LIVER ABSCESS; NONHUMAN; PROTEIN DOMAIN; PROTEIN SECRETION; RODENT; SHORT SURVEY; TH1 CELL; VACCINATION; YERSINIA; YERSINIA ENTEROCOLITICA;

EID: 36749011491     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.07.001     Document Type: Short Survey

References (37)

1. Acuna-Soto R., Maguire J.H., and Wirth D.F. Gender distribution in asymptomatic and invasive amebiasis. Am. J. Gastroenterol. 95 (2000) 1277-1283
2. Black D.S., and Bliska J.B. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37 (2000) 515-527
3. Blessmann J., Van Linh P., Nu P.A., Thi H.D., Muller-Myhsok B., Buss H., and Tannich E. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. Am. J. Trop. Med. Hyg. 66 (2002) 578-583
4. Denis M., and Chadee K. Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. J. Leukoc. Biol. 46 (1989) 270-274
5. Dodson J.M., Lenkowski Jr. P.W., Eubanks A.C., Jackson T.F., Napodano J., Lyerly D.M., Lockhart L.A., Mann B.J., and Petri Jr. W.A. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. J. Infect. Dis. 179 (1999) 460-466
6. Galan J.E., and Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284 (1999) 1322-1328
7. Ghadirian E., and Salimi A. In vitro effect of recombinant interferon gamma in combination with LPS on amoebicidal activity of murine Kupffer cells. Immunobiology 188 (1993) 203-219
8. Gundel I., Weidinger G., ter Meulen V., Heesemann J., Rüssmann H., and Niewiesk S. Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4T cell epitope protects against measles virus-induced encephalitis. J. Gen. Virol. 84 (2003) 775-779
9. Igwe E.I., Rüssmann H., Roggenkamp A., Noll A., Autenrieth I.B., and Heesemann J. Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect. Immun. 67 (1999) 5500-5507
10. Jacobi C.A., Roggenkamp A., Rakin A., Zumbihl R., Leitritz L., and Heesemann J. In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Mol. Microbiol. 30 (1998) 865-882
11. Lin J.Y., Seguin R., Keller K., and Chadee K. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica. Immunology 85 (1995) 400-407
12. Lotter H., Zhang T., Seydel K.B., Stanley Jr. S.L., and Tannich E. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis. J. Exp. Med. 185 (1997) 1793-1801
13. Lotter H., Khajawa F., Stanley Jr. S.L., and Tannich E. Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectin. Infect. Immun. 68 (2000) 4416-4421
14. Lotter H., Rüssmann H., Heesemann J., and Tannich E. Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess. Infect. Immun. 72 (2004) 7318-7321
15. Lotter H., Jacobs T., Gaworski I., and Tannich E. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect. Immun. 74 (2006) 118-124
16. Mann B.J., Burkholder B.V., and Lockhart L.A. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl d-galactosamine inhibitable lectin of Entamoeba histolytica. Vaccine 15 (1997) 659-663
17. McCoy J.J., Mann B.J., Vedvick T.S., Pak Y., Heimark D.B., and Petri Jr. W.A. Structural analysis of the light subunit of the Entamoeba histolytica galactose-specific adherence lectin. J. Biol. Chem. 268 (1993) 24223-24231
18. Pelludat C., Rakin A., Jacobi C.A., Schubert S., and Heesemann J. The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J. Bacteriol. 180 (1998) 538-546
19. Petri W.A., and Ravdin J.I. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect. Immun. 59 (1990) 97-101
20. Petri Jr. W.A., Snodgrass T.L., Jackson T.F., Gathiram V., Simjee A.E., Chadee K., and Chapman M.D. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence. J. Immunol. 144 (1990) 4803-4809
21. Ravdin J.I., Shain D.C., and Kelsall B.L. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica. Vaccine 11 (1993) 241-246
22. Roggenkamp A., Neuberger H.R., Flugel A., Schmoll T., and Heesemann J. Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol. Microbiol. 16 (1995) 1207-1219
23. Roggenkamp A., Bittner T., Leitritz L., Sing A., and Heesemann J. Contribution of the Mn-cofactored superoxide dismutase (SodA) to the virulence of Yersinia enterocolitica serotype O8. Infect. Immun. 65 (1997) 4705-4710
24. Rosqvist R., Forsberg A., Rimpilainen M., Bergman T., and Wolf-Watz H. The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol. Microbiol. 4 (1990) 657-667
25. Rosqvist R., Forsberg A., and Wolf-Watz H. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect. Immun. 59 (1991) 4562-4569
26. Rüssmann H., Weissmuller A., Geginat G., Igwe E.I., Roggenkamp A., Bubert A., Goebel W., Hof H., and Heesemann J. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur. J. Immunol. 30 (2000) 1375-1384
27. Rüssmann H., Gerdemann U., Igwe E.I., Panthel K., Heesemann J., Garbom S., Wolf-Watz H., and Geginat G. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction. Infect. Immun. 71 (2003) 3463-3472
28. Salata R.A., Murray H.W., Rubin B.Y., and Ravdin J.I. The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites. Am. J. Trop. Med. Hyg. 37 (1987) 72-78
29. Seydel K.B., Smith S.J., and Stanley Jr. S.L. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect. Immun. 68 (2000) 400-402
30. Spreng S., Gentschev I., Goebel W., Weidinger G., ter Meulen V., and Niewiesk S. Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis. Microbes Infect. 2 (2000) 1687-1692
31. Tannich E., Ebert F., and Horstmann R.D. Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica. Proc. Natl. Acad. Sci. USA 88 (1991) 1849-1853
32. Von Pawel-Rammingen U., Telepnev M.V., Schmidt G., Aktories K., Wolf-Watz H., and Rosqvist R. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol. Microbiol. 36 (2000) 737-748
33. Walsh J.A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev. Infect. Dis. 8 (1986) 228-238
34. WHO. Amoebiasis. Wkly. Epidemiol. Rec. 72 (1997) 97-99
35. Wiedig C.A., Kramer U., Garbom S., Wolf-Watz H., and Autenrieth I.B. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains. Vaccine 23 (2005) 4984-4998
36. Zhang T., and Stanley Jr. S.L. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect. Immun. 62 (1994) 2605-2608
37. Zhang T., and Stanley Jr. S.L. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess. Infect. Immun. 64 (1996) 1526-1531